Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mark Brower is active.

Publication


Featured researches published by Mark Brower.


Biotechnology Progress | 2015

Advective hydrogel membrane chromatography for monoclonal antibody purification in bioprocessing.

Ying Hou; Mark Brower; David Pollard; Dharmesh Kanani; Renaud Jacquemart; Bradley Kachuik; Jim Stout

Protein A chromatography is widely employed for the capture and purification of monoclonal antibodies (mAbs). Because of the high cost of protein A resins, there is a significant economic driving force to seek new downstream processing strategies. Membrane chromatography has emerged as a promising alternative to conventional resin based column chromatography. However, to date, the application has been limited to mostly ion exchange flow through (FT) mode. Recently, significant advances in Natrix hydrogel membrane has resulted in increased dynamic binding capacities for proteins, which makes membrane chromatography much more attractive for bind/elute operations. The dominantly advective mass transport property of the hydrogel membrane has also enabled Natrix membrane to be run at faster volumetric flow rates with high dynamic binding capacities. In this work, the potential of using Natrix weak cation exchange membrane as a mAb capture step is assessed. A series of cycle studies was also performed in the pilot scale device (> 30 cycles) with good reproducibility in terms of yield and product purities, suggesting potential for improved manufacturing flexibility and productivity. In addition, anion exchange (AEX) hydrogel membranes were also evaluated with multiple mAb programs in FT mode. Significantly higher binding capacity for impurities (support mAb loads up to 10Kg/L) and 40X faster processing speed were observed compared with traditional AEX column chromatography. A proposed protein A free mAb purification process platform could meet the demand of a downstream purification process with high purity, yield, and throughput.


Analytical Chemistry | 2017

On-Line Ion Exchange Liquid Chromatography as a Process Analytical Technology for Monoclonal Antibody Characterization in Continuous Bioprocessing

Bhumit A. Patel; Nuno Pinto; Adrian Gospodarek; Bruce Kilgore; Kudrat Goswami; William N. Napoli; Jayesh Desai; Jun H. Heo; Dominick Panzera; David Pollard; Daisy Richardson; Mark Brower; Douglas D. Richardson

Combining process analytical technology (PAT) with continuous production provides a powerful tool to observe and control monoclonal antibody (mAb) fermentation and purification processes. This work demonstrates on-line liquid chromatography (on-line LC) as a PAT tool for monitoring a continuous biologics process and forced degradation studies. Specifically, this work focused on ion exchange chromatography (IEX), which is a critical separation technique to detect charge variants. Product-related impurities, including charge variants, that impact function are classified as critical quality attributes (CQAs). First, we confirmed no significant differences were observed in the charge heterogeneity profile of a mAb through both at-line and on-line sampling and that the on-line method has the ability to rapidly detect changes in protein quality over time. The robustness and versatility of the PAT methods were tested by sampling from two purification locations in a continuous mAb process. The PAT IEX methods used with on-line LC were a weak cation exchange (WCX) separation and a newly developed shorter strong cation exchange (SCX) assay. Both methods provided similar results with the distribution of percent acidic, main, and basic species remaining unchanged over a 2 week period. Second, a forced degradation study showed an increase in acidic species and a decrease in basic species when sampled on-line over 7 days. These applications further strengthen the use of on-line LC to monitor CQAs of a mAb continuously with various PAT IEX analytical methods. Implementation of on-line IEX will enable faster decision making during process development and could potentially be applied to control in biomanufacturing.


mAbs | 2018

Multi-angle light scattering as a process analytical technology measuring real-time molecular weight for downstream process control

Bhumit A. Patel; Adrian Gospodarek; Michael Larkin; Sophia A. Kenrick; Mark Haverick; Nihal Tugcu; Mark Brower; Douglas D. Richardson

ABSTRACT For many protein therapeutics including monoclonal antibodies, aggregate removal process can be complex and challenging. We evaluated two different process analytical technology (PAT) applications that couple a purification unit performing preparative hydrophobic interaction chromatography (HIC) to a multi-angle light scattering (MALS) system. Using first principle measurements, the MALS detector calculates weight-average molar mass, Mw and can control aggregate levels in purification. The first application uses an in-line MALS to send start/stop fractionation trigger signals directly to the purification unit when preset Mw criteria are met or unmet. This occurs in real-time and eliminates the need for analysis after purification. The second application uses on-line ultra-high performance size-exclusion liquid chromatography to sample from the purification stream, separating the mAb species and confirming their Mw using a µMALS detector. The percent dimer (1.5%) determined by the on-line method is in agreement with the data from the in-line application (Mw increase of approximately 2750 Da). The novel HIC-MALS systems demonstrated here can be used as a powerful tool for real-time aggregate monitoring and control during biologics purification enabling future real time release of biotherapeutics.


Journal of Organic Chemistry | 2004

Stereoselective Synthesis of a Potent Thrombin Inhibitor by a Novel P2−P3 Lactone Ring Opening†

Todd D. Nelson; Carl LeBlond; Doug E. Frantz; Louis Matty; Jeffrey V. Mitten; Damian G. Weaver; Jeffrey C. Moore; Jaehon Kim; Russell Boyd; Pei Yi Kim; Kodzo Gbewonyo; Mark Brower; Michael G. Sturr; Kathleen McLaughlin; Daniel R. McMasters; Michael H. Kress; James M. McNamara; Ulf H. Dolling


Pharmaceutical bioprocessing | 2013

The impact of continuous multicolumn chromatography on biomanufacturing efficiency

Marc Bisschops; Mark Brower


Journal of Molecular Catalysis B-enzymatic | 2006

A novel resolution of a pharmaceutically important bridged bicyclic ketone intermediate via selective enzymatic reduction with a commercially available ketoreductase

Matthew D. Truppo; Jaehon Kim; Mark Brower; Andrew Madin; Michael G. Sturr; Jeffrey C. Moore


Continuous Processing in Pharmaceutical Manufacturing | 2014

Monoclonal Antibody Continuous Processing Enabled by Single Use

Mark Brower; Ying Hou; David Pollard


Archive | 2017

Progress Toward Automated Single-Use Continuous Monoclonal Antibody Manufacturing via the Protein Refinery Operations Lab

David Pollard; Mark Brower; Douglas D. Richardson


Archive | 2017

Delivering a toolbox of flexible platforms for clinical and commercial bioprocessing production: ‘Defining the business drivers for development and implementation’

Mark Brower; David Pollard


Archive | 2017

Continuous bioprocessing and process analytical technologies: A path towards quality by design

Nuno Pinto; Mark Brower; Adrian Gospodarek; William N. Napoli; David Pollard; Douglas D. Richardson

Collaboration


Dive into the Mark Brower's collaboration.

Researchain Logo
Decentralizing Knowledge